About
About Fusen Pharmaceutical Company Limited
Fusen Pharmaceutical Company Limited, an investment holding company, engages in the manufacturing and sale of pharmaceutical products in the People's Republic of China. The company offers Shuanghuanglian oral solutions and injections; Sanhuang tablet; heat-clearing and detoxicating oral solutions; Flunarizine hydrochloride capsules; Sanhuang tablets; compound ferrous sulfate granules; and other pharmaceutical products. It is also involved in manufacturing and sale of pharmaceutical package materials; research and development of pharmaceutical products; sale of construction materials and pharmaceutical products; and provision of business management and consulting services. Its medicines are used for the treatment of heat-clearing and detoxification, cardiovascular and cerebrovascular, antihypertensive and hypoglycemic, tonifying, qi-regulating, anti-anemia, and antibacterial and anti-inflammatory. Fusen Pharmaceutical Company Limited was founded in 2003 and is headquartered in Nanyang, China.
Visit company website
5 years, 4 months ago
Fusen Pharmaceutical Company Limited is currently in a long term downtrend where the price is trading 31.3% below its 200 day moving average.
From a valuation standpoint, the stock is 93.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 7.2.
Fusen Pharmaceutical Company Limited's total revenue rose by 13.5% to $239M since the same quarter in the previous year.
Its net income has increased by 18.2% to $35M since the same quarter in the previous year.
Finally, its free cash flow grew by 130.0% to $53M since the same quarter in the previous year.
Based on the above factors, Fusen Pharmaceutical Company Limited gets an overall score of 4/5.